Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Haidl (Schmallenberg, Germany). LATE-BREAKING ABSTRACT: Effect of inhalation of tobramycin on reduction of hospitalisation rate in severe COPD. Eur Respir J 2012; 40: Suppl. 56, 2894

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: CAT for evaluation of recovery after severe exacerbation of COPD Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 LATE-BREAKING ABSTRACT: Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD patients Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 LATE-BREAKING ABSTRACT: Association of airway bacterial load with inhaled corticosteroid dosage in stable COPD Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts Year: 2012 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Baseline factors and survival difference between normocapnia, compensated respiratory acidosis and decompensated respiratory acidosis in COPD exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 LATE-BREAKING ABSTRACT: Predictive factors of frequent exacerbations in mild grade COPD patients Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 LATE-BREAKING ABSTRACT: Indacaterol/glycopyrronium (IND/GLY) reduces the risk of exacerbations versus salmeterol/fluticasone (SFC) in moderate-to-very severe COPD patients irrespective of prior ICS/LABA/LAMA therapy: The FLAME study Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 LATE-BREAKING ABSTRACT: Effects of a fixed dose once-daily triple drug combination in smokers and non-smokers with COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 LATE-BREAKING ABSTRACT: On the effectiveness of steroids in acute lung injury: Experimental separation between inflammation and hypoxemia Source: Annual Congress 2012 - Novel mechanisms of acute lung injury Year: 2012 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Which predictors in COPD patients with the frequent exacerbator phenotype predict the treatment response to maintenance therapy with azithromycin? Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 LATE-BREAKING ABSTRACT: Lung function assessed by home forced oscillation and self reported symptoms during COPD exacerbations Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with inhaled corticosteroids (ICS): An across-trials model-based approach Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016 LATE-BREAKING ABSTRACT: No relationship between cardiovascular morbidity and moderate-to-severe exacerbation rates in COPD patients in primary care Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 LATE-BREAKING ABSTRACT: The novel inhaled dual PDE3/4 inhibitor RPL554 produces significant additional improvements in lung function when administered on top of existing standard of care in COPD patients Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: Developing obstructive change over time is dominant in small airways in severe asthma Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments Year: 2012